GENB Generate Biomedicines, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $1.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $25.3M | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $16.0K |
| 2026-Q4 | $0 | $184.7K |
Bought$25.3M5 buy days
Sold$200.7K2 sell days
Net insider flow+$25.1Mnet buying · 5 years
Latest trade2026-10-29ARNOLD FRANCES
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | Sell | ARNOLD FRANCES | Director | 11,409 | $16.19 | $184.7K | 1 |
| 2026-09-01 | Sell | ARNOLD FRANCES | Director | 1,000 | $16.00 | $16.0K | 1 |
| 2026-03-04 | Buy | Nally Michael | CEO | 20,000 | $12.00 | $240.0K | 1 |
| 2026-03-02 | Buy | AFEYAN NOUBAR | Director | 1,562,500 | $16.00 | $25.0M | 1 |
| 2026-03-02 | Buy | Silvers Jason | President | 1,500 | $16.00 | $24.0K | 2 |
| 2026-03-02 | Buy | Mendillo Jane L | Director | 1,500 | $16.00 | $24.0K | 1 |
| 2026-03-02 | Buy | Grous Beth | Other C-suite | 300 | $16.00 | $4.8K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| AFEYAN NOUBAR | Director | $25.0M | $0 | 2026-03-02 |
| Nally Michael | CEO | $240.0K | $0 | 2026-03-04 |
| ARNOLD FRANCES | Director | $0 | $200.7K | 2026-10-29 |
| Mendillo Jane L | Director | $24.0K | $0 | 2026-03-02 |
| Silvers Jason | President | $24.0K | $0 | 2026-03-02 |
| Grous Beth | Other C-suite | $4.8K | $0 | 2026-03-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-03-02 → 2026-03-04 | 5 | $25.3M | 51 | +10.4% (+7.7% raw) | -16.0% (-3.2% raw) | +14.3% (+27.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.